Gene G. Kinney

6.3k citations

89 papers · 4.5k indexed · h-index 36

Cellular and Molecular Neuroscience top 0.5%
- Neuroscience and Neuropharmacology Research 32
- Neurotransmitter Receptor Influence on Behavior 8
Biological Psychiatry top 2%
Physiology top 1%
- Alzheimer's disease research and treatments 21
Neurology top 2%
Neurology top 2%
Molecular Biology
- Amyloidosis: Diagnosis, Treatment, Outcomes 22
- Receptor Mechanisms and Signaling 14
Computational Theory and Mathematics
- Computational Drug Discovery Methods 12
Cognitive Neuroscience
- Memory and Neural Mechanisms 11
Oncology
- Drug Transport and Resistance Mechanisms 8

Co-authors: P. Jeffrey Conn Cyrille Sur Bernát Kocsis Robert P. Vertes Maryann Burno Paul J. Shughrue David L. Williams Craig W. Lindsley
Cited by: Cellular and Molecular Neuroscience Biological Psychiatry Physiology
Journals: Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (4 papers)
Partner nations: United States Italy Germany

In The Last Decade

Gene G. Kinney

86 papers receiving 4.4k citations

Peers

Countries citing papers authored by Gene G. Kinney

Since Specialization

Citations

This map shows the geographic impact of Gene G. Kinney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gene G. Kinney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gene G. Kinney more than expected).

Fields of papers citing papers by Gene G. Kinney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gene G. Kinney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gene G. Kinney. The network helps show where Gene G. Kinney may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gene G. Kinney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gene G. Kinney Line = papers co-authored together Gene G. Kinney links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	PRX005, a novel anti‐MTBR tau monoclonal antibody: results from a first‐in‐human double‐blind, placebo‐controlled, single ascending dose phase 1 study Alzheimer s & Dementia ·Ferenc Martényi,Brian Campbell,Gene G. Kinney,Jun Lee,Yuying Jin,Wagner Zago,Hideki Garren	2023	4
2	P56 SURVIVAL BENEFIT OF BIRTAMIMAB IN MAYO STAGE IV AL AMYLOIDOSIS IN THE PHASE 3 VITAL STUDY WAS CONSISTENT ACROSS ALL KEY BASELINE VARIABLES HemaSphere ·Morie A. Gertz,Adam D. Cohen,Raymond L. Comenzo,Efstathios Kastritis,Heather Landau,Edward N. Libby,Michaela Liedtke,Vaishali Sanchorawala,Stefan Schönland,Ashutosh Wechalekar,Yukio Ando,Youngil Koh,Jeffrey A. Zonder,Giovanni Palladini,C. Nie,Carol L. Karp,Yu Jin,Anne Conrad,Gene G. Kinney,Giampaolo Merlini	2023	1
3	Birtamimab in Patients with Mayo Stage IV AL Amyloidosis: Rationale for Confirmatory Affirm-AL Phase 3 Study Design Blood ·Morie A. Gertz,Radhika Tripuraneni,Gene G. Kinney	2021	6
4	First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction Journal of Clinical Oncology ·Morie A. Gertz,Heather Landau,Raymond L. Comenzo,David C. Seldin,Brendan M. Weiss,Jeffrey A. Zonder,Giampaolo Merlini,Stefan Schönland,Jackie Walling,Gene G. Kinney,Martin Koller,Dale B. Schenk,Spencer Guthrie,Michaela Liedtke	2016	147
5	NEOD001 DEMONSTRATES CARDIAC AND RENAL BIOMARKER RESPONSES IN A PHASE 1/2 STUDY IN PATIENTS WITH AMYLOID LIGHT CHAIN AMYLOIDOSIS AND PERSISTENT ORGAN DYSFUNCTION Journal of the American College of Cardiology ·Michaela Liedtke,Raymond L. Comenzo,Heather Landau,David C. Seldin,Brendan M. Weiss,Jeffrey A. Zonder,Jackie Walling,Gene G. Kinney,Martin Koller,Morie A. Gertz	2016	1
6	Emerging drug targets in amyotrophic lateral sclerosis Expert Opinion on Orphan Drugs ·Michael P. Bova,Gene G. Kinney	2012	4
7	Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice Experimental Neurology ·Frédérique Bard,Michael Fox,Stuart Friedrich,Peter Seubert,Dale Schenk,Gene G. Kinney,Ted Yednock	2012	40
8	Acute γ-Secretase Inhibition of Nonhuman Primate CNS Shifts Amyloid Precursor Protein (APP) Metabolism from Amyloid-β Production to Alternative APP Fragments without Amyloid-β Rebound Journal of Neuroscience ·Jacquelynn J. Cook,Kristin R. Wildsmith,David B. Gilberto,Marie A. Holahan,Gene G. Kinney,Parker D. Mathers,Maria S. Michener,Eric A. Price,Mark S. Shearman,Adam J. Simon,Jennifer X. Wang,Guoxin Wu,Kevin E. Yarasheski,Randall J. Bateman	2010	60
9	Discovery of N-{[1-(propylsulfonyl)-4-pyridin-2-ylpiperidin-4-yl]methyl}benzamides as novel, selective and potent GlyT1 inhibitors Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao,William Leister,Julie A. O’Brien,Wei Lemaire,David L. Williams,Marlene A. Jacobson,Cyrille Sur,Gene G. Kinney,D. J. PETTIBONE,Philip R. Tiller,Sheri Smith,George D. Hartman,Craig W. Lindsley,S. E. Wolkenberg	2009	16
10	Discovery of GlyT1 inhibitors with improved pharmacokinetic properties Bioorganic & Medicinal Chemistry Letters ·S. E. Wolkenberg,Zhijian Zhao,David D. Wisnoski,William Leister,Julie L. O'Brien,Wei Lemaire,David L. Williams,Marlene A. Jacobson,Cyrille Sur,Gene G. Kinney,D. J. PETTIBONE,Philip R. Tiller,Sheri Smith,Christopher R. Gibson,Bennett Ma,Stacey L. Polsky-Fisher,Craig W. Lindsley,George D. Hartman	2009	15
11	Design, Synthesis, and In Vivo Efficacy of Glycine Transporter‐1 (GlyT1) Inhibitors Derived from a Series of [4‐Phenyl‐1‐(propylsulfonyl)piperidin‐4‐yl]methyl Benzamides ChemMedChem ·Craig W. Lindsley,Zhijian Zhao,William Leister,Julie L. O'Brien,Wei Lemaire,David L. Williams,Tsing‐Bau Chen,Raymond S.L. Chang,Maryann Burno,Marlene A. Jacobson,Cyrille Sur,Gene G. Kinney,Douglas J. Pettibone,Philip R. Tiller,Sheri Smith,Nancy N. Tsou,Mark E. Duggan,P. Jeffrey Conn,George D. Hartman	2006	32
12	The Role of Amyloid-Beta Derived Diffusible Ligands (ADDLs) in Alzheimers Disease Current Topics in Medicinal Chemistry ·Susan M. Catalano,Elizabeth A. Dodson,Darrell A. Henze,Joseph G. Joyce,Grant A. Krafft,Gene G. Kinney	2006	88
13	The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats Psychopharmacology ·Una C. Campbell,Kush Lalwani,Lisa M. Hernández,Gene G. Kinney,P. Jeffrey Conn,Linda J. Bristow	2004	97
14	Ontogeny of REM sleep in ratspossible implications for endogenous depression Physiology & Behavior ·G Vogel,Pingfa Feng,Gene G. Kinney	2000	48
15	Brainstem carbachol injections in the urethane anesthetized rat produce hippocampal theta rhythm and cortical desynchronization: a comparison of pedunculopontine tegmental versus nucleus pontis oralis injections Brain Research ·Gene G. Kinney,Gerald W. Vogel,Pingfu Feng	1998	44
16	Medial septal unit firing characteristics following injections of 8-OH-DPAT into the median raphe nucleus Brain Research ·Gene G. Kinney,Bernát Kocsis,Robert P. Vertes	1996	49
17	The supramammillary nucleus: Is it necessary for the mediation of hippocampal theta rhythm? Neuroscience ·Jeffrey S. Thinschmidt,Gene G. Kinney,Bernát Kocsis	1995	81
18	Injections of muscimol into the median raphe nucleus produce hippocampal theta rhythm in the urethane anesthetized rat Psychopharmacology ·Gene G. Kinney,Bernát Kocsis,Robert P. Vertes	1995	51
19	Separation of hippocampal theta dipoles by partial coherence analysis in the rat Brain Research ·Bernát Kocsis,Jeffrey S. Thinschmidt,Gene G. Kinney,Robert P. Vertes	1994	11
20	Pharmacological suppression of the median raphe nucleus with serotonin1a agonists, 8-OH-DPAT and buspirone, produces hippocampal theta rhythm in the rat Neuroscience ·Robert P. Vertes,Gene G. Kinney,Bernát Kocsis,William J. Fortin	1994	87

About Gene G. Kinney

Gene G. Kinney is a scholar working on Cellular and Molecular Neuroscience, Physiology and Biochemistry, having authored 89 papers that have together received 4.5k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (32 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (22 papers), Alzheimer's disease research and treatments (21 papers), Receptor Mechanisms and Signaling (14 papers), Computational Drug Discovery Methods (12 papers), Memory and Neural Mechanisms (11 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Drug Transport and Resistance Mechanisms (8 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (2.4k citations), Biological Psychiatry (240 citations) and Physiology (1.4k citations). Gene G. Kinney has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include P. Jeffrey Conn, Cyrille Sur, Bernát Kocsis, Robert P. Vertes, Maryann Burno, Paul J. Shughrue, David L. Williams, Craig W. Lindsley, Wagner Zago and Michael Grundman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact